Cancer tumors in human body.In recent years, cancer research has entered a new frontier, propelled by revolutionary advancements in chemistry. Among these innovations, photoredox catalysis and micro mapping are emerging as game-changers, paving the way for more targeted, precise, and effective cancer therapies. Leading these transformative efforts is Sir David W.C. MacMillan, a Nobel Prize-winning chemist, whose groundbreaking work promises to shift the paradigm of how we treat and understand cancer. One of the standout innovations introduced by MacMillan is the use of photoredox catalysis, a technique that leverages visible light to activate molecules in a precise and controlled manner.…
Author: by NANCY WAINAINA
The 2018 Nobel Prize in Chemistry, Molecular biologist Sir. Gregory P. Winter with Prof. Martin Chalfie 2008 Nobel Prize in Chemistry.The story of monoclonal antibodies is a testament to the transformative power of scientific innovation combined with strategic business decisions. Monoclonal antibodies (mAbs) are lab-made proteins that act like human antibodies and can be used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. They are designed to target specific antigens on cells, like those found on cancer cells, and can either attack the cells directly or deliver other treatments like chemotherapy drugs. These targeted therapies have…